Matthew Brams insider trades

Open-market stock purchases and sales by Matthew Brams, EVP and Chief Medical Officer at Cingulate Inc, from SEC Form 4 filings since Dec 7, 2021.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -11%.

Recent trades

DateStockTradeValue
Mar 9, 2026CING Cingulate IncBought (not open market)—
Mar 9, 2026CING Cingulate IncSold (not open market)—
Feb 6, 2026CING Cingulate IncBought$156
Feb 6, 2026CING Cingulate IncBought$9.8K

Companies traded

  • CING Cingulate Inc: 2 buys, last Mar 9, 2026

Get free alerts when Matthew Brams files a new trade →